https://doi.org/10.1038/ncomms6241
M
María Angélica Cortez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
238
Papers
9.6K
Citations
45
h-index
69
i10-index
María Angélica Cortez is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Cancer Research and Treatments. The author has an h-index of 45, co-authored 203 publications.
ORCID: 0000-0002-3130-4002Papers by this author
worksMetastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
2014 · Nature Communications · 970 citations
Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
2015 · Cancer Discovery · 883 citations
https://doi.org/10.1158/2159-8290.cd-14-1236
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
2009 · Expert Opinion on Biological Therapy · 438 citations
https://doi.org/10.1517/14712590902932889
Altered cancer metabolism in mechanisms of immunotherapy resistance
2018 · Pharmacology & Therapeutics · 181 citations
https://doi.org/10.1016/j.pharmthera.2018.11.004
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
2015 · Molecular Therapy — Nucleic Acids · 70 citations
https://doi.org/10.1038/mtna.2015.47
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
2017 · Nature Communications · 50 citations
https://doi.org/10.1038/s41467-017-01562-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat